BiotechTube
Home/NK:IO/Professor Hugh Brady
PH

Professor Hugh Brady

Co-founder, Chief Scientific Officer, Director

NK:IO

Therapeutic Areas

Oncology

NK:IO Pipeline

DrugIndicationPhase
wNK:IO CellsHaematological and solid tumoursPreclinical
eNK:IO CellsHard-to-treat cancer subtypesPreclinical
dNK:IO REV-ERB AntagonistsCancer, long-term pathogen infectionResearch

Leadership Team at NK:IO

DA
Dr. Andrew Baxendale
Chief Operating Officer
View full NK:IO profile